AbCellera Biologics Inc (ABCL)
3.865
-0.04
(-1.15%)
USD |
NASDAQ |
Apr 19, 16:00
3.87
0.00 (0.00%)
After-Hours: 19:10
AbCellera Biologics Price to Book Value: 0.9821 for April 19, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 0.9935 |
| April 17, 2024 | 0.996 |
| April 16, 2024 | 1.029 |
| April 15, 2024 | 1.062 |
| April 12, 2024 | 1.103 |
| April 11, 2024 | 1.113 |
| April 10, 2024 | 1.133 |
| April 09, 2024 | 1.202 |
| April 08, 2024 | 1.141 |
| April 05, 2024 | 1.103 |
| April 04, 2024 | 1.118 |
| April 03, 2024 | 1.113 |
| April 02, 2024 | 1.098 |
| April 01, 2024 | 1.128 |
| March 28, 2024 | 1.151 |
| March 27, 2024 | 1.141 |
| March 26, 2024 | 1.09 |
| March 25, 2024 | 1.164 |
| March 22, 2024 | 1.166 |
| March 21, 2024 | 1.197 |
| March 20, 2024 | 1.202 |
| March 19, 2024 | 1.169 |
| March 18, 2024 | 1.166 |
| March 15, 2024 | 1.197 |
| March 14, 2024 | 1.194 |
| Date | Value |
|---|---|
| March 13, 2024 | 1.248 |
| March 12, 2024 | 1.240 |
| March 11, 2024 | 1.260 |
| March 08, 2024 | 1.212 |
| March 07, 2024 | 1.248 |
| March 06, 2024 | 1.237 |
| March 05, 2024 | 1.222 |
| March 04, 2024 | 1.270 |
| March 01, 2024 | 1.283 |
| February 29, 2024 | 1.283 |
| February 28, 2024 | 1.291 |
| February 27, 2024 | 1.301 |
| February 26, 2024 | 1.258 |
| February 23, 2024 | 1.237 |
| February 22, 2024 | 1.232 |
| February 21, 2024 | 1.222 |
| February 20, 2024 | 1.349 |
| February 16, 2024 | 1.357 |
| February 15, 2024 | 1.342 |
| February 14, 2024 | 1.317 |
| February 13, 2024 | 1.290 |
| February 12, 2024 | 1.378 |
| February 09, 2024 | 1.290 |
| February 08, 2024 | 1.267 |
| February 07, 2024 | 1.239 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9579
Minimum
Oct 27 2023
175.28
Maximum
Dec 11 2020
5.714
Average
2.418
Median
Jun 28 2022
Price to Book Value Benchmarks
| Acasti Pharma Inc | 0.4170 |
| Aurinia Pharmaceuticals Inc | 1.917 |
| Edesa Biotech Inc | 2.420 |
| Lexaria Bioscience Corp | 4.268 |
| InMed Pharmaceuticals Inc | 0.1381 |
Price to Book Value Related Metrics
| PS Ratio | 29.39 |
| Price | 3.865 |
| Earnings Yield | -13.45% |
| Market Cap | 1.132B |